South Korea Drug Delivery Devices Market Report by Mode of Administration (Injectable, Topical, Ocular, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2026-2034
South Korea drug delivery devices market size reached USD 8.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.3 Billion by 2034, exhibiting a growth rate (CAGR) of 7 .10% during 2026-2034 . The development of advanced healthcare infrastructure in South Korea, steadily expanding geriatric population base, rising prevalence of lifestyle-related diseases, presence of a robust manufacturing industry, and increasing government funding and favorable regulations represent some of the key factors driving the market.
Drug delivery devices refer to specialized tools engineered for the controlled release of therapeutic agents, ensuring their efficient transport to the targeted areas within the body. It includes syringes, infusion pumps, inhalers, and transdermal patches. They are constructed from various materials, such as plastics, metals, and silicones, that are biocompatible and approved for medical use. Drug delivery devices are comprised of several components, such as a reservoir for the drug, a shield or case, and a mechanism for controlled drug release. They offer several features, such as programmable settings, portability, and ease of use. Drug delivery devices are widely used for diabetes management, cardiovascular treatments, respiratory therapies, oncology, neurological conditions, and hormonal replacement therapies, among others. They aid in enhancing patient compliance, improving therapeutic efficacy, minimizing side effects, easing administration, and augmenting patient safety. Furthermore, drug delivery devices offer several advantages, such as consistency, precision, reliability, adaptability, efficiency, cost-effectiveness, versatility, user-friendliness, and broader applicability in complex medical conditions.
SOUTH KOREA DRUG DELIVERY DEVICES MARKET TRENDS:
The development of advanced healthcare infrastructure in South Korea, which is conducive to the adoption of high-end medical technologies, including drug delivery devices, is propelling the market growth. Additionally, the burgeoning geriatric population, which is increasing the demand for chronic disease management, thereby escalating the need for efficient drug delivery systems, is contributing to the market growth. Besides this, the rising prevalence of lifestyle-related diseases such as diabetes and cardiovascular disorders, which necessitates the use of specialized drug delivery devices for effective management, is catalyzing the market growth. Furthermore, the presence of a robust pharmaceutical industry in South Korea, which presents an advantageous ecosystem for the synergistic development of medications and corresponding delivery devices, is positively impacting the market growth. In addition to this, the increasing government funding and favorable regulations that are promoting medical research and commercialization of advanced drug delivery systems are bolstering the market growth. Apart from this, recent technological advancements in materials science contributing to the development of more biocompatible and effective devices are favoring the market growth. Moreover, the significant growth in home healthcare services, which is enabling wider adoption of user-friendly drug delivery systems, is supporting the market growth significantly. Along with this, the heightened patient awareness and acceptance of the product, making it easier for healthcare providers to incorporate these devices into treatment, is fueling the market growth. In addition to this, the growing medical tourism in South Korea, which is boosting healthcare standards and driving demand for advanced medical technologies, is strengthening the market growth.
SOUTH KOREA DRUG DELIVERY DEVICES MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on mode of administration and end user.
Mode of Administration Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea drug delivery devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea drug delivery devices market?
What is the breakup of the South Korea drug delivery devices market on the basis of mode of administration?
What is the breakup of the South Korea drug delivery devices market on the basis of end user?
What are the various stages in the value chain of the South Korea drug delivery devices market?
What are the key driving factors and challenges in the South Korea drug delivery devices?
What is the structure of the South Korea drug delivery devices market and who are the key players?
What is the degree of competition in the South Korea drug delivery devices market?
Drug delivery devices refer to specialized tools engineered for the controlled release of therapeutic agents, ensuring their efficient transport to the targeted areas within the body. It includes syringes, infusion pumps, inhalers, and transdermal patches. They are constructed from various materials, such as plastics, metals, and silicones, that are biocompatible and approved for medical use. Drug delivery devices are comprised of several components, such as a reservoir for the drug, a shield or case, and a mechanism for controlled drug release. They offer several features, such as programmable settings, portability, and ease of use. Drug delivery devices are widely used for diabetes management, cardiovascular treatments, respiratory therapies, oncology, neurological conditions, and hormonal replacement therapies, among others. They aid in enhancing patient compliance, improving therapeutic efficacy, minimizing side effects, easing administration, and augmenting patient safety. Furthermore, drug delivery devices offer several advantages, such as consistency, precision, reliability, adaptability, efficiency, cost-effectiveness, versatility, user-friendliness, and broader applicability in complex medical conditions.
SOUTH KOREA DRUG DELIVERY DEVICES MARKET TRENDS:
The development of advanced healthcare infrastructure in South Korea, which is conducive to the adoption of high-end medical technologies, including drug delivery devices, is propelling the market growth. Additionally, the burgeoning geriatric population, which is increasing the demand for chronic disease management, thereby escalating the need for efficient drug delivery systems, is contributing to the market growth. Besides this, the rising prevalence of lifestyle-related diseases such as diabetes and cardiovascular disorders, which necessitates the use of specialized drug delivery devices for effective management, is catalyzing the market growth. Furthermore, the presence of a robust pharmaceutical industry in South Korea, which presents an advantageous ecosystem for the synergistic development of medications and corresponding delivery devices, is positively impacting the market growth. In addition to this, the increasing government funding and favorable regulations that are promoting medical research and commercialization of advanced drug delivery systems are bolstering the market growth. Apart from this, recent technological advancements in materials science contributing to the development of more biocompatible and effective devices are favoring the market growth. Moreover, the significant growth in home healthcare services, which is enabling wider adoption of user-friendly drug delivery systems, is supporting the market growth significantly. Along with this, the heightened patient awareness and acceptance of the product, making it easier for healthcare providers to incorporate these devices into treatment, is fueling the market growth. In addition to this, the growing medical tourism in South Korea, which is boosting healthcare standards and driving demand for advanced medical technologies, is strengthening the market growth.
SOUTH KOREA DRUG DELIVERY DEVICES MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on mode of administration and end user.
Mode of Administration Insights:
- Injectable
- Topical
- Ocular
- Others
End User Insights:
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea drug delivery devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea drug delivery devices market?
What is the breakup of the South Korea drug delivery devices market on the basis of mode of administration?
What is the breakup of the South Korea drug delivery devices market on the basis of end user?
What are the various stages in the value chain of the South Korea drug delivery devices market?
What are the key driving factors and challenges in the South Korea drug delivery devices?
What is the structure of the South Korea drug delivery devices market and who are the key players?
What is the degree of competition in the South Korea drug delivery devices market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA DRUG DELIVERY DEVICES MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - BREAKUP BY MODE OF ADMINISTRATION
6.1 Injectable
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Topical
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Ocular
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Others
6.4.1 Historical and Current Market Trends (2020-2025)
6.4.2 Market Forecast (2026-2034)
7 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - BREAKUP BY END USER
7.1 Hospitals
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Ambulatory Surgical Centers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Others
7.3.1 Historical and Current Market Trends (2020-2025)
7.3.2 Market Forecast (2026-2034)
8 SOUTH KOREA DRUG DELIVERY DEVICES MARKET – BREAKUP BY REGION
8.1 Seoul Capital Area
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Mode of Administration
8.1.4 Market Breakup by End User
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Yeongnam (Southeastern Region)
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Mode of Administration
8.2.4 Market Breakup by End User
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Honam (Southwestern Region)
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Mode of Administration
8.3.4 Market Breakup by End User
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Hoseo (Central Region)
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Mode of Administration
8.4.4 Market Breakup by End User
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA DRUG DELIVERY DEVICES MARKET – COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 PROFILES OF KEY PLAYERS
10.1 Company A
10.1.1 Business Overview
10.1.2 Product Portfolio
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Product Portfolio
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Product Portfolio
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Product Portfolio
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Product Portfolio
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - INDUSTRY ANALYSIS
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA DRUG DELIVERY DEVICES MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - BREAKUP BY MODE OF ADMINISTRATION
6.1 Injectable
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Topical
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Ocular
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Others
6.4.1 Historical and Current Market Trends (2020-2025)
6.4.2 Market Forecast (2026-2034)
7 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - BREAKUP BY END USER
7.1 Hospitals
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Ambulatory Surgical Centers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Others
7.3.1 Historical and Current Market Trends (2020-2025)
7.3.2 Market Forecast (2026-2034)
8 SOUTH KOREA DRUG DELIVERY DEVICES MARKET – BREAKUP BY REGION
8.1 Seoul Capital Area
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Mode of Administration
8.1.4 Market Breakup by End User
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Yeongnam (Southeastern Region)
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Mode of Administration
8.2.4 Market Breakup by End User
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Honam (Southwestern Region)
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Mode of Administration
8.3.4 Market Breakup by End User
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Hoseo (Central Region)
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Mode of Administration
8.4.4 Market Breakup by End User
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA DRUG DELIVERY DEVICES MARKET – COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 PROFILES OF KEY PLAYERS
10.1 Company A
10.1.1 Business Overview
10.1.2 Product Portfolio
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Product Portfolio
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Product Portfolio
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Product Portfolio
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Product Portfolio
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 SOUTH KOREA DRUG DELIVERY DEVICES MARKET - INDUSTRY ANALYSIS
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 APPENDIX
